<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34163090</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID in a prospective cohort of home-isolated patients.</ArticleTitle><Pagination><StartPage>1607</StartPage><EndPage>1613</EndPage><MedlinePgn>1607-1613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-021-01433-3</ELocationID><Abstract><AbstractText>Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16-30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blomberg</LastName><ForeName>Bj&#xf8;rn</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5647-4297</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.blomberg@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway. bjorn.blomberg@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway. bjorn.blomberg@uib.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohn</LastName><ForeName>Kristin Greve-Isdahl</ForeName><Initials>KG</Initials><Identifier Source="ORCID">0000-0002-3249-1719</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brokstad</LastName><ForeName>Karl Albert</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linchausen</LastName><ForeName>Dagrun Waag</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Bergen Municipality Emergency Clinic, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Bent-Are</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lartey</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyango</LastName><ForeName>Therese Bredholt</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwelker</LastName><ForeName>Kanika</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1302-950X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe6;vik</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4670-4957</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartsch</LastName><ForeName>Hauke</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1486-4128</Identifier><AffiliationInfo><Affiliation>Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Informatics, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xf8;ndel</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3389-3194</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research and Innovation, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kittang</LastName><ForeName>B&#xe5;rd Reiakvam</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Bergen COVID-19 Research Group</CollectiveName></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cox</LastName><ForeName>Rebecca Jane</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-8341-4078</Identifier><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. rebecca.cox@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, Bergen, Norway. rebecca.cox@uib.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Langeland</LastName><ForeName>Nina</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0278-1616</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway. nina.langeland@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway. nina.langeland@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway. nina.langeland@uib.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010356" MajorTopicYN="N">Patient Isolation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Madsen</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bredholt</LastName><ForeName>Geir</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vahokoski</LastName><ForeName>Juha</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fjelltveit</LastName><ForeName>Elisabeth Berg</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bansal</LastName><ForeName>Amit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trieu</LastName><ForeName>Mai Chi</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ljostveit</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olofsson</LastName><ForeName>Jan Stefan</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ertesv&#xe5;g</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sandnes</LastName><ForeName>Helene Heitmann</ForeName><Initials>HH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corydon</LastName><ForeName>Anette</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xf8;yland</LastName><ForeName>Hanne</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eidsheim</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jakobsen</LastName><ForeName>Kjerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guldseth</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauge</LastName><ForeName>Synn&#xf8;ve</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34163090</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pii">10.1038/s41591-021-01433-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A, et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nat. Med.26, 1803 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. 2020;26:1037&#x2013;1040. doi: 10.1038/s41591-020-0916-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395:e109. doi: 10.1016/S0140-6736(20)31282-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31282-4</ArticleId><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr WR, Coghlan JD, Payne DJ, Robertson L. The laboratory diagnosis of chronic brucellosis. Lancet. 1966;2:1181&#x2013;1183. doi: 10.1016/S0140-6736(66)90492-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(66)90492-2</ArticleId><ArticleId IdType="pubmed">4162551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayres JG, Smith EG, Flint N. Protracted fatigue and debility after acute Q fever. Lancet. 1996;347:978&#x2013;979. doi: 10.1016/S0140-6736(96)91470-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91470-1</ArticleId><ArticleId IdType="pubmed">8598797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanevik K, et al. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin. Infect. Dis. 2014;59:1394&#x2013;1400. doi: 10.1093/cid/ciu629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu629</ArticleId><ArticleId IdType="pmc">PMC4207419</ArticleId><ArticleId IdType="pubmed">25115874</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358:1946&#x2013;1954. doi: 10.1016/S0140-6736(01)06961-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)06961-6</ArticleId><ArticleId IdType="pubmed">11747919</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am. J. Med. 2000;109:531&#x2013;537. doi: 10.1016/S0002-9343(00)00560-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(00)00560-X</ArticleId><ArticleId IdType="pubmed">11063953</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J. Clin. Virol. 2007;38:1&#x2013;6. doi: 10.1016/j.jcv.2006.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.10.011</ArticleId><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Geense, W. W. et al. New physical, mental, and cognitive problems 1-year post-ICU: a prospective multicenter study. Am. J. Respir. Crit. Care Med.10.1164/rccm.202009-3381OC (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33526001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwelker, K. et al. Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: a case-ascertained study. Lancet Reg. Health Eur.3, 100014 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009692</ArticleId><ArticleId IdType="pubmed">33871470</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani DF, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437&#x2013;442. doi: 10.1038/s41586-020-2456-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2456-9</ArticleId><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel JH, et al. Remdesivir for the treatment of Covid-19&#x2014;final report. N. Engl. J. Med. 2020;383:1813&#x2013;1826. doi: 10.1056/NEJMoa2007764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, et al. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147&#x2013;153. doi: 10.1016/0022-3999(93)90081-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely S, Powell R. Fatigue syndromes: a comparison of chronic &#x2018;postviral&#x2019; fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry. 1989;52:940&#x2013;948. doi: 10.1136/jnnp.52.8.940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.52.8.940</ArticleId><ArticleId IdType="pmc">PMC1031831</ArticleId><ArticleId IdType="pubmed">2571680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J. Psychosom. Res. 1998;45:53&#x2013;65. doi: 10.1016/S0022-3999(97)00291-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(97)00291-2</ArticleId><ArticleId IdType="pubmed">9720855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 2020;11:5493. doi: 10.1038/s41467-020-19057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 2020;26:1033&#x2013;1036. doi: 10.1038/s41591-020-0913-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0913-5</ArticleId><ArticleId IdType="pmc">PMC8183627</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>Trieu MC, et al. SARS-CoV-2-specific neutralizing antibody responses in Norwegian health care workers after the first wave of COVID-19 pandemic: a prospective cohort study. J. Infect. Dis. 2021;223:589&#x2013;599. doi: 10.1093/infdis/jiaa737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa737</ArticleId><ArticleId IdType="pmc">PMC7798943</ArticleId><ArticleId IdType="pubmed">33247924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>